Carl Zeiss Meditec Names Bronwyn Brophy O'Connor CEO Effective Dec. 1, 2026
Bitget2026/10/26 09:30- Carl Zeiss Meditec appoints Bronwyn Brophy O'Connor CEO effective December 1, 2026.
- She succeeds Andreas Pecher, who has served as interim CEO since January 1, 2026.
- Brophy O'Connor has led Sweden's Vitrolife Group as CEO since 2023, following senior roles at Thermo Fisher Scientific and Medtronic.
- She will also join Carl Zeiss's Executive Board on December 1, 2026, with responsibility for the Medical Technology segment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Shares of Australia's SCX.ai surge due to SpaceX partnership
Zcash co-founder releases ZIP proposal to "terminate ZCG funding channel and instead support NSM"
Citadel warns: Tech stock sell-off is just the first warning sign, AI trading offers "almost no room for error"
The sell-off in tech stocks reflects rising doubts about AI profitability, with Citadel stating that there is very little margin for error in AI trading. Grayscale noted that demand is parabolic, and capital expenditure presents a two-sided risk.
Daiwa raises Tesla's target price to $390
Crypto prices
More
